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Abstract: The utilization of graphene-based nanomaterials combined with magnetic nanopar-
ticles offers key benefits in the modern biomedicine. In this minireview, we focus on the most 
recent advances in hybrids of magnetic graphene derivatives for biomedical applications. We 
initially analyze the several methodologies employed for the preparation of graphene-based 
composites with magnetic nanoparticles, more specifically the kind of linkage between the 
two components. In the last section, we focus on the biomedical applications where these 
magnetic-graphene hybrids are essential and pay special attention on how the addition of gra-
phene improves the resulting devices in magnetic resonance imaging, controlled drug deliv-
ery, magnetic photothermal therapy and cellular separation and isolation. Finally, we high-
light the use of these magnetic hybrids as multifunctional material that will lead to a next gen-
eration of theranostics. 
Keywords: Graphene, graphene derivatives, magnetic nanoparticles, biomedical application, magnetic resonance 
imaging, drug delivery, photothermal therapy, cellular separation. 
1. INTRODUCTION 
The recent discovery of grapheme [1] has produced 
broad research attention to explore the possibilities of 
this new material in biomedical applications, mainly 
due to the characteristic structure and the extraordinary 
set of physicochemical properties [2]. Graphene is a 
single atomic layer of sp2 carbon atoms arranged in a 
honeycomb lattice of nanometer dimensions. Besides, 
various derivatives of graphene can also be defined, in 
relation to the number of layers, layer dimensions and 
amount of oxygen present in the graphene structure [3]. 
In this way, in addition to graphene, other graphene-
based materials (GBMs) of high importance in bio-
medical applications appear: graphene oxide (GO), re-
duced graphene oxide (rGO) and graphene quantum 
dots (GQDs). GO material is considered a graphene 
derivative with large amount of oxygen-containing 
groups, mainly epoxy, carbonyl and hydroxyl groups,  
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while rGO is the reduced form of GO [4]. On the other 
hand, GQDs consist of quasi-spherical graphene 
nanoparticles with layer dimensions of less than 10 
nanometers and showing a graphene quantum effect 
[5]. 
Magnetic nanoparticles (MNPs) have been used in 
biomedical applications such as biosensing, drug deliv-
ery, hyperthermia, magnetic resonance imaging (MRI) 
and cellular capture [6]. Iron oxide nanoparticles 
(IONPs) are among the most used nanoparticles for 
magnetic applications [7]. Depending on their size, 
IONPs can be divided in: i) superparamagnetic 
(SPION), when sizes are larger than 50nm; ii) ultras-
mall (USPION), with sizes below 50 nm; and iii) mi-
cron-sized (MPION), which are almost macroscopic 
with sizes above 1 μm. However, MNPs present sev-
eral limitations: for instance, they tend to aggregate and 
precipitate inside the biological vessels, thus reducing 
their stability, biocompatibility and efficiency. The 
combination of MNPs with carbon-based nanostruc-
tures has recently attracted huge interest in biomedicine 
because the resulting hybrids allow to overcome the 
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MNP limitations and take advantage of the intrinsic 
properties of both materials [8]. The controlled growth 
of these IONPs on any of the forms of graphene sur-
faces (G, GO, rGO and GQD) opens the door to a new 
set of materials with enhanced efficiency in the com-
mon bioapplications of MNPs, mainly in the area of 
diagnosis and the treatment of cancer cells. The large 
surface area of graphene makes these nanoparticles 
effective drug carriers [9], while the magnetic proper-
ties from the IONPs convert them as contrast agents for 
MRI [10]. Graphene-based hybrids with MNPs are a 
research trend that has been increasing in the last few 
years (Fig. 1). 
 
Fig. (1). Number of articles published since 2007 to mid-
2016 based on “graphene” and “magnetic nanoparticles”, 
according to Web of Knowledge database. 
Several reviews have been published, collecting the 
application of the different carbon nanomaterials with 
MNPs in biomedicine [11]. Accordingly, this minire-
view will focus only on the latest developments in 
biomedical applications using hybrids based on MNPs 
with “young” carbon nanoforms, such as GBMs. Par-
ticularly, we will highlight the application of GBM-
MNP hybrids in MRI, drug delivery, photothermal 
therapy (PTT) and cellular uptake and isolation. Fur-
thermore, we will pay special attention to multifunc-
tional GBM-MNP hybrids within the above-mentioned 
applications. 
2. PREPARATION OF GBM-MNP HYBRIDS 
The preparation of GBM-MNP hybrids involves the 
modification of graphene materials. There are two main 
strategies to derivatize GBMs: the covalent and the 
non-covalent approach [2c,4,12]. In particular, covalent 
functionalization is the most frequently employed route 
to modify carbon materials, as this methodology yields 
products of high stability over time. It is carried out by 
several methods: the formation of covalent bonds by 
radical and cycloaddition reactions at sp2 carbon bonds 
and the formation of covalent attachment through 
modification of oxygenated functional groups. On the 
other hand, non-covalent modifications mainly include 
hydrophobic and Van der Waals forces, electrostatic 
interaction, hydrogen bonding, and π -π stacking inter-
action. 
The synthesis of GBM-MNP hybrids can be catego-
rized under two main approaches: ex situ and in situ 
methods [11d, 11e]. The former involves a previous 
synthesis of MNPs and their subsequent attachment on 
graphene surfaces by either covalent or non covalent 
modification. This approach may also imply a previous 
chemical functionalization of both materials [13]. 
However, the most employed methodology is the in 
situ deposition of MNPs on graphene material. The 
commonly used MNP precursors are inorganic salts 
[14] and mineral sources, such as magnetite [15]. Re-
lated to the carbon component of hybrids, oxidized 
graphene materials are excellent platforms for this pur-
pose, as the presence of defects and oxygenated groups 
favors the growth and attachment of MNPs. 
3. BIOMEDICAL APPLICATION OF THE MAG-
NETIC GRAPHENE 
It is well known that any kind of nanoparticles can 
be delivered to tumoral tissue in two modes: (i) via ac-
tive targeting, where the NPs are functionalized with 
antibodies and peptides with high affinity to the spe-
cific tumor cells receptors; (ii) through passive target-
ing, according to which positively charged NPs accu-
mulate at tumor sites due to the leaky vasculature and 
low functional immune system of the area [9]. In any 
case, the accumulation depends on the nanometer size, 
the pore diameters of the tumor surfaces, the blood cir-
culation half-life and the degree of tumor vasculariza-
tion. 
3.1. Magnetic Resonance Imaging 
The inherent magnetic properties of IONPs make 
them excellent contrast agents for MRI. However, 
these nanoparticles tend to aggregate and precipitate 
inside the body vessels, thus reducing the circulation 
time in blood and the efficiency as contrast agents for 
long period imaging. As a solution, graphene-based 
materials have been employed as a support material to 
anchor IONPs and enhance the physiological stability 
of the contrast agent [13a,15a]. Indeed, it was observed 
that the aggregation of IONPs on GO surface improved 
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significantly the T2 relaxivity of the system in compari-
son to the IONPs alone (Fig. 2).  
The first cellular imaging test using aminodextran-
coated IONPs on GO sheets was reported in 2011 by 
Chen et al (Fig. 2) [16]. However, further enhancement 
of the T2 relaxivities was desired, in order to apply such 
hybrids into MRI cellular labeling in vivo. In this line, 
Venkatesha and co-workers demonstrated the impor-
tance of the arrangement of the IONPs on the GO sur-
face in GO-IONP hybrids in order to control the trans-
verse proton relaxivity [17]. The authors observed that 
high amounts of carboxyl groups and a large number of 
IONPs enhanced the relaxivity value, and concluded 
that such tendency is due to a synergistic effect be-
tween the reduction of GO and the arrangement of 
IONPs. Chen and co-workers developed a new method 
to assemble nanoparticles in several morphologies and 
composition onto GO sheets [18]. They demonstrated 
that the in situ growth of β-FeOOH nanorods onto 
PEG-GO sheets enhance the transverse relaxivity up to 
60 times in comparison to the β-FeOOH-based contrast 
agents alone. Further studies demonstrated that even at 
low iron concentrations in the IONPs-PEG-GO nano-
composites, the cellular MRI is always improved [13a]. 
In summary, there are plenty of studies demonstrat-
ing that the presence of graphene-based nanomaterials 
as contrast agents always enhance the MRI signal, 
which can be tuned by controlling the aggregation of 
the MNPs on the graphene framework.  
3.2. Controlled-release Drug Delivery Nanocarriers 
In the recent years, graphene-IO hybrids have been 
extensively used for drug release in tumor cells and 
tissues. The functional groups of GO and RGO have 
been confirmed to allow higher loadings, since their  
 
large surface area allows supporting large amounts of 
drug [11a, 11d]. However, not only achieving a high 
drug loading is important for a successful therapeutic 
effect, but also delivering it to the desired cell or tissue. 
The superparamagnetic properties of IO are useful here 
to provide guiding and targeting of the delivery using 
an external magnetic field and MRI. In summary, gra-
phene-IO hybrids benefit the drug delivery in terms of 
higher loading and controlled deliveries over graphene 
or IONPs alone, thus improving the efficiency of the 
final system.  
Doxorubin (DOX) has been regularly used as a 
chemotherapeutic agent due to its strong cell-killing 
ability. However, DOX use for cancer treatment is lim-
ited, due to its toxic effects. In order to increase the 
efficacy of this kind of antitumor drugs and reduce its 
toxicity, it is mandatory to deliver the drugs directly to 
its target and maintain its concentration during the 
therapeutic time [19]. Controlled-release nanosystems 
for drug delivery have become the most promising 
nanocarriers for therapeutics. Such control is a key fea-
ture that can be achieved using switchable gates around 
the nanocomposite that can be sequentially opened and 
closed by specific stimuli, such as temperature, pH or 
light. In this line, Yang and co-workers prepared the 
first superparamagnetic GO-IONP hybrid with pH-
triggered control for controlled targeted drug delivery 
[20]. In this work, the authors loaded the hybrid system 
with DOX anticancer agent through physical absorp-
tion on the GO surface to test their binding and deliv-
ery properties. In addition, due to the inherent optical 
absorbance of GO in the NIR region, the hybrid was 
also proposed for photothermal therapy (PTT). In 2013, 
Balcioglu et al. further developed this hybrid by adding 
AuNPs, resulting in an improvement of the DOX en-
capsulation [21]. 
Fig. (2). T2 weighted MR images: HeLa cells incubated with the IONPs-GO hybrids at different concentrations (A) and at dif-
ferent cell densities (B) for 24h. Reprinted from Ref. [16], Copyright 2011 American Chemical Society. 
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Wang et al. incorporated chitosan onto rGO-
SPIONs nanosheets to improve their stability, solubil-
ity and biocompatibility for cancer chemotherapy and 
gene therapy [22]. The resulting nanocarrier demon-
strated an efficient drug loading capacity, pH-
dependent release and good cytotoxicity. DOX was 
then absorbed on the surface and the resultant compos-
ite was encapsulated with a reporter DNA sequence 
and a green fluorescent protein (GFP) through their 
interaction with the positively charged chitosan. The 
delivery of both DOX and DNA was studied in vitro 
and in tumor bearing mice and followed through MRI, 
and the results demonstrated that the final composite 
DOX-(chitosan magnetic-G)-GFP-DNA was highly 
distributed along the tumor site. Furthermore, toxicity 
studies confirmed that there was no body weight loss of 
the treated mice. 
As well, a carbon nanotube (CNT)-graphene 
nanosheet (GN)-IONPs hybrid was prepared by loading 
5-fluorouracil (5-FU) anticancer drug via a green ap-
proach and tested as an excellent pH-sensitive thera-
peutic nanocarrier for anti-cancer drug delivery [23]. 
The authors observed that the incorporation of the CNT 
enhanced the transportation of the composite across the 
cell membrane, as shown by TEM microscopy. Fur-
thermore, they also realized that drug release was 
higher in the acid environment of the typical cancer 
cells. 
In a recent study, drug nanocarriers based on 
mesoporous silica-coated magnetic GO were synthe-
sized for anti-cancer drug delivery of DOX [24]. The 
addition of mesoporous silica increases the surface 
area, thus drug loading, as well as the cellular uptake. 
Such carriers were designed with a dendrimer-like 
structure based on supramolecular poly-pseudoro-
taxane; such structures are commonly used in targeted 
drug delivery and act as molecular gates storing the 
drugs that can be opened by an external stimulus, in 
this case, a pH change. The resulting system, a part 
from the pH-sensitivity, has high colloidal stability and 
positive charge surface, what favors the cellular uptake.  
3.3. Magnetic-photothermal Therapy (mPTT) 
Although body temperatures above 37ºC are com-
monly defined fever and associated to an illness, a 
temperature increase in specific targeted tissues has 
been observed to have multiple therapeutic benefits in 
patients with cancer [25]. It has been reported that hy-
perthermia, a controlled increase of temperatures be-
tween 41ºC and 48ºC in localized areas, is clinically 
relevant for thermal treatments and causes minimal 
side effects to healthy organs, compared to radiother-
apy and chemotherapy [26]. Among the novel tools and 
techniques, the focus has mainly been addressed to 
photothermal therapy (PTT), due to its high selectivity 
and minimal invasiveness. This therapy is based on 
nanoparticles with photoabsorbing capability to gener-
ate heat under NIR irradiation, thus causing thermal 
ablation of cancer cells. These nanoparticles are nor-
mally delivered to tumors before the treatment. Gra-
phene-based structures have become potential agents 
for PTT due to their high absorbance in the NIR range. 
Moreover, depositions of IONP on GO produce hybrid 
nanoparticles that can be magnetically guided to the 
tumor target and enhance therapy selectivity, as well as 
improving the light-to-heat conversion [11a]. However, 
the limited penetration depth of NIR irradiation inside 
tissues may cause incomplete ablation of large or deep 
tumors and the use of a high power may damage the 
neighbor healthy tissues. One solution might be the 
magnetic localized hyperthermia, which utilizes mag-
netic nanoparticles directly injected or guided to the 
tumor area of the patients to induce heat through an 
external alternating current magnetic field (ACMF). 
Heat is generated due to hysteresis loss, and induces 
the apoptosis of tumor cells without damaging nearby 
healthy tissue [27]. The magnetic properties of these 
NPs not only permit the magneto-photothermal ther-
apy, but also provide the tool to image and monitor the 
tumor response to the therapy.  
Yang et al. developed rGO-IONP-PEG nanocompo-
sites in 2012 and applied them for the first time as 
agents for magnetic PTT and magnetic guiding in vivo 
[28]. Using the same system, Fu and co-workers treated 
tumor models through PTT and monitored its response 
via MRI and analyzed the tumor apparent diffusion 
coefficient (ADC), concluding that photothermal 
agents, magnetic guidance and drug-light intervals can 
all affect the PTT efficiency (Fig. 3) [29]. Also rGO 
was combined with superparamagnetic zinc ferrite 
spinel (ZnFe2O4) and showed high efficiency as a mag-
neto-PTT agent in low concentrations and minimal cy-
totoxicity [30]. 
Hydrogels have been extensively applied in bio-
medicine due to its hydrated environment and tunable 
properties similar to the native extracellular matrix. 
Zhu and co-workers designed a magnetic thermo-
sensitive hydrogel based on GO, IONP and polyethyle-
neimine carrying DOX [31]. The authors demonstrated 
not only the successful delivery of DOX, but also an 
improvement of the therapeutic effect in presence of an 
ACMF and a reduction of its toxicity.  
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3.4. Cellular Capture and Isolation 
All untreated biological materials, such as the circu-
lating tumor cells (CTCs) and other rare cells, are dia-
magnetic by nature, thus there exist a chance of sepa-
rating them selectively from the whole blood using 
magnetic nanoplatforms and external magnetic cur-
rents. In this line, plasmonic-magnetic GO, formed by 
the attachment of iron and gold nanoparticles, was 
loaded with anti-GD2 antibody to detect malignant 
melanoma UACC903 at extremely low concentrations 
(up to 10 cells per mL) and separate them from whole 
blood sample using a magnetic bar [32]. In addition, 
the gold shell allowed the SERS plasmon enhancement, 
thus improving the detection of the captured cells.  
Shi and co-workers have recently developed a novel 
GOQDs-IONPs hybrid charged with anti-Glypican-3 
(GOC3) antibody to capture selectively low-
concentrated hepatocellular carcinoma (HCC) tumor 
cells in an infected blood sample (Fig. 4). This ap-
proach was shown as a very potentially non-invasive 
tool to detect early stages of liver cancer, with capture 
efficiencies of about 91% [33]. Furthermore, an aligned 
Ni-micropillar device decorated with GO and IONPs 
was developed to control both the capture and the re-
lease of cancer cells upon application or removal of a 
magnetic field [34]. 
3.5. Multifuctional Applications 
Adding IONPs, thus adding magnetic properties, to 
graphene-based materials, generates new theranostic 
functionalities to these novel hybrids: not only gra-
phene-IONPs drug nanocarriers can be imaged through 
MRI, but also, once deposited on tumor sites, can be 
used as photothermal therapy agents and kill cancer 
cells very efficiently [35]. Both drug release and PTT 
are activated through an external stimulus, which is 
commonly AMF or NIR; however, they have some 
limitations: NIR has a low penetration inside tissues 
but a high efficiency in eradicating cancer cells, while 
AMF has a deeper penetration but narrower efficiency 
in ablation. Therefore, the combination of both meth-
odologies may provide an outstanding material for drug 
delivery as well as hyperthermia treatment (Fig. 5) 
[36]. 
In order to exploit the intrinsic properties of gra-
phene-based MNPs, the combination of multifunctional 
theranostics has gained huge attention in the recent 
years [13a, 37]. Among the most promising publica-
tions, Deng et al. synthesized an innovative hybrid 
“micro-matryoshka” platform comprising GO, IONP 
and polysaccharides (alginine, chitosan and hyaluronic 
acid able to bind cancer cells and load drugs through 
pH control, while dual magnetic and NIR PTT induces 
 
Fig. (3). Preparation of IONP hybrids with PEGylated GO and representation of their PTT application. Reprinted from Ref. 
[29], Copyright 2016 American Chemical Society. 
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Fig. (4). Schematic representation of the synthesis of GOQDs- IONPs loaded with the antibody GOC3 and their application in 
the selective Separation of Tumor Cells. Reprinted from Ref. [33], Copyright 2015 American Chemical Society. 
 
 
Fig. (5). Schematic illustration of preparation and action mechanism of hybrid capsules synthesized layer-by-layer assembly. 
Reprinted from Ref. [36], Copyright 2016 American Chemical Society. 
hyperthermia ablation of the tumor. The authors per-
formed their successful assays both in vitro and in vivo 
and claimed that the whole process was highly control-
lable [36]. Even more, GO-IONPs hybrids were tested 
to co-deliver simultaneously several anticancer drugs 
and, in combination with NIR-induced hyperthermia, 
were demonstrated to achieve in vivo a tumor inhibi-
tory rate of 73.9% [38].  
Also iron-cobalt (FeCo) MNPs have been deposited 
on graphene aiming to saturate the magnetization as an 
MRI contrast agent. The system was also confirmed to 
be an excellent DOX delivery system and an excep-
tional PTT agent [39]. 
CONCLUSION 
The combination of GBMs, carrying remarkable 
structural and physicochemical properties, with MNP is 
producing outstanding magnetic hybrids with improved 
functionalities for nanobiotechnology and biomedicine 
applications. This fact is clearly reflected in the expo-
nential growth of their publication numbers in the past 
several years. Although GBM-MNP hybrids are in its 
“infancy”, the preliminary results are encouraging. 
However, the field is still far from clinical applications, 
which require addressing some of the remaining chal-
lenges. GBMs obviously display many advantages 
compared with other systems, with the ability to pro-
vide efficient MNP loading capacity using very simple 
preparation procedures. Besides, their intrinsic charac-
teristic allows designing complex multifunctional sys-
tems as new direction to produce theranostic agents. 
In summary, we have selectively reviewed the ulti-
mate and promising advances in the biomedical appli-
cations of GBM-MNP hybrids with special attention in 
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MRI, drug delivery, PTT and cellular capture and isola-
tion. We believe that such applications will be rapidly 
enhanced in the forthcoming years. 
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